Litcius/Paper detail

IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer

Ri Sa, Rui Liang, Xian Qiu, Ziyan He, Zhiyan Liu, Libo Chen

2021Cancer Letters61 citationsDOI

Topics & Concepts

Cancer researchBiologyTyrosine kinaseSodium-iodide symporterGene knockdownSignal transductionEndocrinologyInternal medicineSymporterCell biologyMedicineCell cultureBiochemistryGeneticsTransporterGeneRNA modifications and cancerCancer-related Molecular PathwaysThyroid Cancer Diagnosis and Treatment
IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer | Litcius